Citation Impact
Citing Papers
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2017 Standout
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Infective Endocarditis
2005 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation
2002
Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications
2015 Standout
Relative contributions of myeloperoxidase and NADPH-oxidase to the early host defense against pulmonary infections withCandida albicansandAspergillus fumigatus
2002
Efficacy and Safety of Voriconazole in the Treatment of Acute Invasive Aspergillosis
2002 Standout
HLA Match Likelihoods for Hematopoietic Stem-Cell Grafts in the U.S. Registry
2014 Standout
A randomized comparison of fluconazole with amphotericin B as empiric anti-fungal agents in cancer patients with prolonged fever and neutropenia
1998
Voriconazole brain tissue levels in rhinocerebral aspergillosis in a successfully treated young woman
2006
Disseminated Mucormycosis Caused by Absidia corymbifera Leading to Cerebral Vasculitis
2000
Cytokines in the treatment of fungal infections
1994
Amphotericin B versus amphotericin B plus 5-flucytosine: Poor results in the treatment of proven systemic mycoses in neutropenic patients
1994
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
Improved outcome in central nervous system aspergillosis, using voriconazole treatment
2005
Use of amphotericin B aerosols for the prevention of pulmonary aspergillosis
1994
Nuclear Factor-κB — A Pivotal Transcription Factor in Chronic Inflammatory Diseases
1997 Standout
The Effect of Prophylactic Fluconazole on the Clinical Spectrum of Fungal Diseases in Bone Marrow Transplant Recipients with Special Attention to Hepatic Candidiasis: An Autopsy Study of 355 Patients
1998
Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease
2007 Standout
INFECTIONS FOLLOWING HEMATOPOIETIC STEM CELL TRANSPLANTATION
2001
Intravenous Itraconazole Followed by Oral Itraconazole in the Treatment of Invasive Pulmonary Aspergillosis in Patients with Hematologic Malignancies, Chronic Granulomatous Disease, or AIDS
2001
Role of early diagnosis and aggressive surgery in the management of invasive pulmonary aspergillosis in neutropenic patients
2001
Intravenous Itraconazole followed by Oral Itraconazole for the Treatment of Amphotericin-B-Refractory Invasive Pulmonary Aspergillosis
2003
Invasive Aspergillosis Clinical Features of 35 Proven Cases at a Single Institution
1998
Refractory Aspergillus pneumonia in patients with acute leukemia
2003
Environmental sampling for aspergilli during building construction on a hospital site
1994
Amphotericin B prophylaxis against invasive fungal infections in neutropenic patients: A single center experience from 1980 to 1995
1996
Placental Blood as a Source of Hematopoietic Stem Cells for Transplantation into Unrelated Recipients
1996
Therapeutic Outcome in Invasive Aspergillosis
1996
Fungal Endocarditis: Evidence in the World Literature, 1965-1995
2001
The glyoxylate cycle is required for fungal virulence
2001 Nature
Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes
2007 Standout
Liposomal amphotericin B as early empiric antimycotic therapy of pneumonia in granulocytopenic patients
1996
Relevant imaging findings of cerebral aspergillosis on MRI: a retrospective case‐based study in immunocompromised patients
2007
Pulmonary Candidiasis in Patients with Cancer: An Autopsy Study
2002
Epidemiology of Nosocomial Fungal Infections, with Emphasis on Candida Species
1995
Fluconazole
1990
Hematopoietic growth factors in cancer patients with invasive fungal infections
1997
Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases
2005 Standout
Cerebral aspergillosis: tissue penetration is the key
2009
1997 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Unexplained Fever
1997
An EORTC multicentre prospective survey of invasive aspergillosis in haematological patients: Diagnosis and therapeutic outcome
1998
Invasive aspergillosis caused by Aspergillus terreus: an emerging opportunistic infection with poor outcome independent of azole therapy
2014
Infections in patients with cancer undergoing chemotherapy: aetiology, prevention, and treatment
2003
Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery.
1997
Aggressive surgical management in localized pulmonary mycotic and nonmycotic infections for neutropenic patients with acute leukemia: Report of eighteen cases
1998
Outcomes among 562 Recipients of Placental-Blood Transplants from Unrelated Donors
1998 Standout
Ten-year air sample analysis of Aspergillus prevalence in a university hospital
2007
Trends in the postmortem epidemiology of invasive fungal infections at a University Hospital
1996 Standout
Echinocandin antifungal drugs
2003 Standout
Diagnosis of pulmonary aspergillosis using optical brighteners
2000
Aspergillosis Case-Fatality Rate: Systematic Review of the Literature
2001 Standout
A multicenter, randomized trial of fluconazole versus amphotericin B for empiric antifungal therapy of febrile neutropenic patients with cancer
2000
The challenge of emerging and re-emerging infectious diseases
2004 StandoutNature
NF-κB regulation in the immune system
2002 Standout
The role of combination antifungal therapy in the treatment of invasive aspergillosis: a systematic review
2011
Aspergillus antigenuria compared to antigenemia in bone marrow transplant recipients
1994
Voriconazole: A New Triazole Antifungal Agent
2003 Standout
High‐dose therapy with fluconazole ≥ 800 mg day‐1
1997
Antifungal agents: An overview. Part II
1994
Antimicrobial reactive oxygen and nitrogen species: concepts and controversies
2004 Standout
Randomized Placebo‐Controlled Trial of Fluconazole Prophylaxis for Neutropenic Cancer Patients: Benefit Based on Purpose and Intensity of Cytotoxic Therapy
1999
A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies
1999
Itraconazole for prophylaxis of systemic mycoses in neutropenic patients with haematological malignancies
1996
Immunity to fungal infections
2011 Standout
Exacerbation of invasive aspergillosis by the immunosuppressive fungal metabolite, gliotoxin
1996
Rhinocerebral Mucormycosis Treated with Amphotericin B Colloidal Dispersion in Three Patients
1998
Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients: Guidelines of the infectious diseases working party of the German Society of Haematology and Oncology
2009
Impact of Previous Aspergillosis on the Outcome of Bone Marrow Transplantation
1998
The Potential Role of Cytokine Therapy for Fungal Infections in Patients with Cancer: Is Recovery from Neutropenia all that is Needed?
1998
Localization of Aspergillosis to the Central Nervous System Among Patients with Acute Leukemia: Report of 14 Cases
1996
Hepatosplenic Candidiasis in Patients with Acute Leukemia: Incidence and Prognostic Implications
1997
In-vitro activity of voriconazole against Aspergillus spp. and comparison with itraconazole and amphotericin B
1998
Epidemiology and Outcome of Mould Infections in Hematopoietic Stem Cell Transplant Recipients
2002 Standout
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
2007 Standout
Resveratrol Suppresses TNF-Induced Activation of Nuclear Transcription Factors NF-κB, Activator Protein-1, and Apoptosis: Potential Role of Reactive Oxygen Intermediates and Lipid Peroxidation
2000 Standout
Fluconazole tolerance in clinical isolates of Cryptococcus neoformans
1997
Candida Infections of Medical Devices
2004 Standout
The Anti-inflammatory Sesquiterpene Lactone Helenalin Inhibits the Transcription Factor NF-κB by Directly Targeting p65
1998 Standout
Diagnostic Accuracy of PCR Alone Compared to Galactomannan in Bronchoalveolar Lavage Fluid for Diagnosis of Invasive Pulmonary Aspergillosis: a Systematic Review
2012
The Epidemiological Features of Invasive Mycotic Infections in the San Francisco Bay Area, 1992-1993: Results of Population-Based Laboratory Active Surveillance
1998
Empirical Amphotericin B therapy on Day 4 or Day 8 of Febrile Neutropenia
2013
Evidence-based assessment of primary antifungal prophylaxis in patients with hematologic malignancies
2003
[Invasive aspergillosis and bone marrow allograft].
1994
NF-kappa B as a frequent target for immunosuppressive and anti-inflammatory molecules.
1997
The immunosuppressive fungal metabolite gliotoxin specifically inhibits transcription factor NF-kappaB.
1996
Pregnancies following high-dose cyclophosphamide with or without high- dose busulfan or total-body irradiation and bone marrow transplantation
1996
Itraconazole resistance in Aspergillus fumigatus
1997
American Society of Clinical Oncology Recommendations on Fertility Preservation in Cancer Patients
2006 Standout
Current and Emerging Azole Antifungal Agents
1999 Standout
Antifungal prophylaxis during neutropenia and immunodeficiency
1997
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for azole antifungal susceptibility testing
1995
Klebsiella pneumoniae: Going on the Offense with a Strong Defense
2016 Standout
2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer
2002 Standout
Alteration of Cell Wall Composition Leads to Amphotericin B Resistance in Aspergillus flavus
1999
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Is there a rationale for the use of antimicrobial prophylaxis in neutropenic patients?
1997
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Antifungal Distribution Into Cerebrospinal Fluid, Vitreous Humor, Bone, and Other Difficult Sites
2010
Consenso Manejo racional del paciente con cáncer, neutropenia y fiebre: Rational approach towards the patient with cancer, fever and neutropenia
2005
Intravenous and Oral Itraconazole versus Intravenous Amphotericin B Deoxycholate as Empirical Antifungal Therapy for Persistent Fever in Neutropenic Patients with Cancer Who Are Receiving Broad-Spectrum Antibacterial Therapy
2001
Worldwide emergence of resistance to antifungal drugs challenges human health and food security
2018 StandoutScience
Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections
2010 Standout
General primer-mediated PCR for detection of Aspergillus species
1994
Aspergillus fumigatusand Aspergillosis
1999 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Treatment of Severe Candida Infections in High-Risk Patients in Germany: Consensus Formed by a Panel of Interdisciplinary Investigators
2002
Practical modalities for prevention of fungal infections in cancer patients
1997
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2017 Standout
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
2008 Standout
Diagnosis of Invasive Septate Mold Infections
2003
Comparison of antigen detection and PCR assay using bronchoalveolar lavage fluid for diagnosing invasive pulmonary aspergillosis in patients receiving treatment for hematological malignancies
1995
Specific recognition of purified Cu,Zn superoxide dismutase from Aspergillus fumigatus by immune human sera
1995
2015 ESC Guidelines for the management of infective endocarditis
2015 Standout
HOW NEUTROPHILS KILL MICROBES
2005 Standout
Molecular Typing of Environmental and Patient Isolates of Aspergillus fumigatus from Various Hospital Settings
1998
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
Itraconazole Preexposure Attenuates the Efficacy of Subsequent Amphotericin B Therapy in a Murine Model of Acute Invasive Pulmonary Aspergillosis
2002
Guidelines for Treatment of Candidiasis
2004 Standout
In vivo immunosuppressive activity of gliotoxin, a metabolite produced by human pathogenic fungi
1994
Phosphorylation Meets Ubiquitination: The Control of NF-κB Activity
2000 Standout
Risk assessment in haematopoietic stem cell transplantation: Conditioning
2007
Hidden Killers: Human Fungal Infections
2012 Standout
Increasing Volume and Changing Characteristics of Invasive Pulmonary Aspergillosis on Sequential Thoracic Computed Tomography Scans in Patients With Neutropenia
2001
Activity of voriconazole (UK-109,496) against clinical isolates of Aspergillus species and its effectiveness in an experimental model of invasive pulmonary aspergillosis
1997
Strategies in prevention of invasive pulmonary aspergillosis in immunosuppressed or neutropenic patients
1994
Works of S. Milliken being referenced
The prophylaxis of fungal infections
1991
Fungal infections in cancer patients: An international autopsy survey
1992
A comparison of the pattern of interstitial pneumonitis following allogeneic bone marrow transplantation before and after the introduction of prophylactic ganciclovir therapy in 1989
1998
Teicoplanin compared to flucloxacillin for antibiotic treatment of neutropenic patients
1990
Pharmacokinetics of oral fluconazole in autologous bone marrow transplantation recipients given TBI and high-dose melphalan.
1989
Rhizopus microsporus var. rhizopodiformis sinus–orbital zygomycosis in an immunosuppressed patient: successful treatment with posaconazole after a complicated clinical course
2007
Successful pregnancy following bone marrow transplantation for leukaemia.
1990
The use of melphalan in conjunction with total body irradiation as treatment for acute leukaemia.
1989